EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Italian Experience with Long-Acting Buprenorphine Formulations (LAIB) for the Treatment of Opioid Use Disorder: A Series of Narrative Interviews

Vincenza Ariano, Anna Francesca Costanzo, Gemma Ferrante, Rossella Garofano, Vincenzo Lamartora, Sergio Manfré, Deborah Nordici, Lorenzo Somaini

International Journal of Environmental Research and Public Health · 07.03.2026 · 23 (3) · 336

DOI: 10.3390/ijerph23030336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, online erschienen am 07.03.2026. Verfasst von Vincenza Ariano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathological Addictions, Local Health Authority (ASL) Taranto, 74121 Taranto, Italy. Hauptthemen laut MEDLINE: Buprenorphine, Opioid-Related Disorders, Opiate Substitution Treatment, Narcotic Antagonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-Acting Buprenorphine Formulations (LAIB) have emerged as an alternative pharmacological approach for opioid use disorder, offering potential benefits extending beyond clinical stabilisation. Narrative medicine provides a unique approach to understand patients’ perspectives and experiences with sublingual buprenorphine and LAIB dispensed to fourteen patients across different Italian Addiction Services, examining how they impact the emotional, social, and motivational dimensions of recovery. Narratives were analysed by thematic content across eight domains: dependence on daily treatment regimen, emotional impact, self-perception, determination to change, quality of life, craving and withdrawal symptoms, treatment adherence, social burden, and therapeutic relationship. Statements were categorised by valence; experiential patterns were qualitatively analysed. Sublingual buprenorphine, although effective, was associated with reduced autonomy, symptom control, and difficulties in balancing treatment, work and life. These aspects were correlated with worse adherence. The stigma and burden of daily intake can reduce motivation and hinder identity reconstruction. In this setting, transitioning to LAIB resulted in improved self-autonomy, emotional balance, symptom control, self-esteem, and reduced daily and psychological burden, craving and stigma, facilitating social reintegration, and strengthening the therapeutic relationship. The results emphasise the importance of including both experiential and narrative elements in clinical care, as this helps create more tailored, recovery-focused treatment pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BuprenorphineOpioid-Related DisordersOpiate Substitution TreatmentNarcotic AntagonistsHumansItalyFemaleAdultDelayed-Action PreparationsMaleMiddle AgedNarrationAdministration, SublingualQuality of Life

Stichwörter der Autor:innen

LAIBlong-acting buprenorphinenarrative medicineopioid agonist therapypatient engagementpatient experience

Substanzen

BuprenorphineDelayed-Action PreparationsNarcotic Antagonists

Autor:innen und Institutionen

  • Department of Pathological Addictions, Local Health Authority (ASL) Taranto, 74121 Taranto, Italy.
  • Azienda Socio-Sanitaria Territoriale Fatebenefratelli-Sacco (ASST Fatebenefratelli-Sacco), Addiction Services (Ser.D) Piazzale Accursio 7, 20149 Milano, Italy.
  • Department of Pathological Addictions, Addiction Services (Ser.D) Pozzuoli, 80078 Pozzuoli, Italy.
  • Department of Mental Health and Addiction, Addiction Services (Ser.D) Avellino, 83100 Avellino, Italy.
  • Addiction Service, Ser.T Monza, 20900 Monza, Italy.
  • Departmental Addictions Area-Asugi, 34128 Trieste, Italy.

Zitieren

APA

Ariano, V., Costanzo, A. F., Ferrante, G., Garofano, R., Lamartora, V., Manfré, S., Nordici, D., & Somaini, L. (2026). Exploring the Italian Experience with Long-Acting Buprenorphine Formulations (LAIB) for the Treatment of Opioid Use Disorder: A Series of Narrative Interviews. International Journal of Environmental Research and Public Health, 23(3), 336. https://doi.org/10.3390/ijerph23030336

Vancouver

Ariano V, Costanzo AF, Ferrante G, Garofano R, Lamartora V, Manfré S, et al. Exploring the Italian Experience with Long-Acting Buprenorphine Formulations (LAIB) for the Treatment of Opioid Use Disorder: A Series of Narrative Interviews. International Journal of Environmental Research and Public Health. 2026;23(3):336. doi:10.3390/ijerph23030336

BibTeX
@article{Ariano2026,
  author = {Ariano, Vincenza and Costanzo, Anna Francesca and Ferrante, Gemma and Garofano, Rossella and Lamartora, Vincenzo and Manfré, Sergio and Nordici, Deborah and Somaini, Lorenzo},
  title = {Exploring the Italian Experience with Long-Acting Buprenorphine Formulations (LAIB) for the Treatment of Opioid Use Disorder: A Series of Narrative Interviews},
  journal = {International Journal of Environmental Research and Public Health},
  year = {2026},
  volume = {23},
  number = {3},
  pages = {336},
  doi = {10.3390/ijerph23030336}
}
Kostenlos starten →